Works matching AU Rawlins, M. D.
1
- 2000
- Guyot, Andrea;
- Rawlins, Matthew D. M.;
- Barrett, Steve P.;
- Guyot, A;
- Rawlins, M D;
- Barrett, S P
- Letter
2
- 2021
- Misko, Jeanie;
- Rawlins, Matthew D. M.
- Letter to the Editor
3
- British Journal of Dermatology, 1983, v. 108, n. 2, p. 222
- Smith, K.;
- Shuster, S.;
- Walton, S.;
- Rawlins, M. D.
- Article
4
- 1981
- Shuster, Sam;
- Rawlins, M. D.;
- Kersey, P. J.;
- Chapman, P. H.
- Letter
5
- British Journal of Dermatology, 1980, v. 103, n. 1, p. 23, doi. 10.1111/j.1365-2133.1980.tb15833.x
- Shuster, Sam;
- Rawlins, M. D.;
- Chapman, P. H.;
- Rogers, Sarah
- Article
6
- British Journal of Dermatology, 1979, v. 101, n. 1, p. 101
- Chapman, P. H.;
- Rawlins, M. D.;
- Shuster, S.
- Article
7
- 2022
- Misko, Jeanie;
- Rawlins, Matthew D. M.;
- Jenkins, Barry
- Letter to the Editor
8
- Journal of Pharmacy Practice & Research, 2021, v. 51, n. 5, p. 437, doi. 10.1002/jppr.1762
- Cheaib, Angela;
- Rawlins, Matthew D. M.;
- Thorson, Rachel E.;
- Beaton, Stephen;
- Hill, Mark;
- Howes, Marten
- Article
9
- Journal of Pharmacy Practice & Research, 2021, v. 51, n. 2, p. 106, doi. 10.1002/jppr.1723
- Rawlins, Matthew D. M.;
- Misko, Jeanie;
- Roberts, Jason A.
- Article
10
- 1987
- Simpson, Judy M.;
- Bateman, D. N.;
- Rawlins, M. D.;
- Simpson, J M
- journal article
11
- Pharmacoepidemiology & Drug Safety, 1992, v. 1, n. 5, p. 261, doi. 10.1002/pds.2630010508
- Rawlins, M. D.;
- Fracchia, G. N.;
- Rodriguez-Farré, E.
- Article
12
- Pharmacoepidemiology & Drug Safety, 1992, v. 1, n. 1, p. 19, doi. 10.1002/pds.2630010105
- Mann, R. D.;
- Rawlins, M. D.;
- Fletcher, P.;
- Wood, S. M.
- Article
13
- Journal of Chemotherapy (Taylor & Francis Ltd), 2018, v. 30, n. 1, p. 59, doi. 10.1080/1120009X.2017.1336318
- Rawlins, Matthew D. M.;
- Sanfilippo, Frank M.;
- Ingram, Paul R.;
- McLellan, Duncan G. J.;
- Crawford, Colin;
- D’Orsogna, Luca;
- Dyer, John
- Article
14
- International Journal of Clinical Pharmacy, 2020, v. 42, n. 5, p. 1379, doi. 10.1007/s11096-020-01067-4
- Nguy, Jenny;
- Hitchen, Sarah A.;
- Hort, Adam L.;
- Huynh, Cindy;
- Rawlins, Matthew D. M.
- Article
15
- International Journal of STD & AIDS, 2016, v. 27, n. 1, p. 33, doi. 10.1177/0956462415573122
- Braun, Lesley A.;
- Forrester, Catherine A.;
- Rawlins, Matthew D. M.;
- Levy, Russell W.;
- Penm, Jonathan;
- Graham, Marissa M.;
- Mackie, Kathryn F.;
- Aran, Sohileh;
- Bridle, Sylvia;
- Bailey, Michael J.;
- Duncan, Alison J.
- Article
16
- Pharmacoepidemiology & Drug Safety, 2001, v. 10, n. 4, p. 303, doi. 10.1002/pds.598
- Aziz, E. E.;
- Ayis, S.;
- Gould, F. K.;
- Rawlins, M. D.
- Article
17
- 2018
- Rawlins, Matthew D M;
- Raby, Edward;
- Sanfilippo, Frank M;
- Douglass, Rae;
- Chambers, Jonathan;
- McLellan, Duncan;
- Dyer, John R
- journal article
18
- Infectious Diseases & Therapy, 2021, v. 10, n. 1, p. 61, doi. 10.1007/s40121-020-00392-5
- Cairns, Kelly A.;
- Rawlins, Matthew D. M.;
- Unwin, Sean D.;
- Doukas, Fiona F.;
- Burke, Rosemary;
- Tong, Erica;
- Henderson, Andrew J.;
- Cheng, Allen C.
- Article
20
- 1978
- Rawlins, Michael D.;
- Rawlins, M D
- journal article
22
- Antimicrobial Stewardship & Healthcare Epidemiology, 2023, v. 3, n. 1, p. 1, doi. 10.1017/ash.2023.120
- Rawlins, Matthew D. M.;
- Boan, Peter A.
- Article
23
- 2022
- Bazargani, Shiva;
- Rawlins, Matthew D. M.;
- Mclellan, Duncan G. J.;
- Ingram, Paul R.;
- Dyer, John R.
- Letter to the Editor
24
- Pharmacoepidemiology (2813-0618), 2023, v. 2, n. 4, p. 328, doi. 10.3390/pharma2040028
- Misko, Jeanie;
- Rawlins, Matthew D. M.
- Article
25
- 1992
- Isah, A O;
- Rawlins, M D;
- Bateman, D N
- Journal Article
26
- Xenobiotica, 1986, v. 16, n. 3, p. 205
- Williams, F. M.;
- Rettie, A. E.;
- Rawlins, M. D.
- Article
27
- Xenobiotica, 1985, v. 15, n. 7, p. 599
- Lambert, D.;
- James, O. F. W.;
- Williams, F. M.;
- Mutch, E.;
- Rawlins, M. D.;
- Woodhouse, K. W.
- Article
28
- 2025
- Misko, Jeanie;
- Rawlins, Matthew D M
- Letter to the Editor
29
- Biopharmaceutics & Drug Disposition, 1992, v. 13, n. 6, p. 403, doi. 10.1002/bdd.2510130603
- Kamali, F.;
- Rawlins, M. D.
- Article
30
- Alimentary Pharmacology & Therapeutics, 1995, v. 9, n. 1, p. 57, doi. 10.1111/j.1365-2036.1995.tb00352.x
- BROWN, A. St., J. M.;
- FIATARONE, J. R.;
- WOOD†, P.;
- BENNETT†, M. K.;
- KELLY, P. J.;
- RAWLINS†, M. D.;
- DAY, C. P.;
- JAMES, O. F. W.
- Article
31
- Alimentary Pharmacology & Therapeutics, 1994, v. 8, n. 3, p. 337, doi. 10.1111/j.1365-2036.1994.tb00297.x
- TURNER, I. B.;
- RAWLINS, M. D.;
- WOOD, P.;
- JAMES, O. F. W.
- Article
32
- 1997
- Rawlins, M. D.;
- Breckenridge, A. M.;
- Wood, S. M.;
- Waller, P. C.;
- Coulson, R.
- Editorial
33
- Annals of Neurology, 1983, v. 14, n. 1, p. 38, doi. 10.1002/ana.410140107
- Turnbull, D. M.;
- Rawlins, M. D.;
- Weightman, D.;
- Chadwick, D. W.
- Article
34
- Clinical Pharmacology & Therapeutics, 1986, v. 39, n. 4, p. 477, doi. 10.1038/clpt.1986.83
- Lemberger, Louis;
- Rawlins, M D
- Article